fbpx
QQQ
+ 9.45
304.69
+ 3.01%
DIA
+ 6.79
301.99
+ 2.2%
SPY
+ 9.42
370.59
+ 2.48%
TLT
-2.06
145.18
-1.44%
GLD
-0.29
162.13
-0.18%

Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest ROE

by
November 29, 2012 3:19 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest ROE

Below are the top drugs-generic stocks on the NASDAQ in terms of return on equity.

The trailing-twelve-month return on equity at Akorn (NASDAQ: AKRX) is 18.99%. Akorn’s revenue for the same period is $227.26 million.

The trailing-twelve-month return on equity at Hi Tech Pharmacal Co (NASDAQ: HITK) is 18.38%. Hi Tech Pharmacal’s operating margin for the same period is 24.58%.

The trailing-twelve-month return on equity at Salix Pharmaceuticals (NASDAQ: SLXP) is 15.84%. Salix Pharmaceuticals had $775.90 million in total cash for the latest quarter.

The trailing-twelve-month return on equity at Mylan (NASDAQ: MYL) is 14.65%. Mylan’s PEG ratio is 0.72.

Posted-In:

Trading Ideas

Related Articles

33 Stocks Moving in Wednesday's Pre-Market Session

Gainers Greenpro Capital Corp. (NASDAQ: GRNQ) shares rose 47.8% to $1.22 in pre-market trading after jumping over 33% on Tuesday. read more

96 Biggest Movers From Yesterday

Gainers Mmtec, Inc. (NASDAQ: MTC) shares climbed 86.4% to close at $2.05 on Tuesday after reporting its financial results for the year ended December 31, 2019. Revenues jumped 647% to $200,797, in 2019. read more

61 Stocks Moving In Tuesday's Mid-Day Session

Gainers Mmtec, Inc. (NASDAQ: MTC) shares jumped 98.2% to $2.18 in pre-market trading after reporting its financial results for the year ended December 31, 2019. Revenues jumped 647% to $200,797, in 2019. read more

28 Stocks Moving in Tuesday's Pre-Market Session

Gainers Mmtec, Inc. (NASDAQ: MTC) shares rose 77.2% to $1.95 in pre-market trading after reporting its financial results for the year ended December 31, 2019. Revenues jumped 647% to $200,797,in 2019. read more